6Goldratt EM. Critical chain [ M ]. Great Barrington, Mass. , USA: The North River Press Publishing Corporation, 1997.
7Leach LP. Critical chain project management [ M ]. 2nd ed. London, UK: Artech House Effective Project Management Library, 2005.
8Newblod RC. Project management in the fast lane applying the theory of constraints[ M ]. Boca Raton. , Fla. , USA: The St. Lucie Press, 1998.
9Herroelen W, Leus R. On the merits and pitfalls of critical chain scheduling[ J ]. Journal of Operations Management, 2001, 19 (5) : 559 -577.
10Blaekstone JH, Cox JF, Schlcier JG. A tutorial on project management from a theory of constraints perspective [ J ]. International Journal of Product Research, 2009, 47 (24) : 7029 - 7046.
2[3]Torzewski J,Torzewski M,Bowyer DE,et al.C-reactive-protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary,arteries[J].Arterioscler Thromb Vasc Biol,1998,18:1386-1392.
3[5]Haverkate F,Thompson SG,Pyke SD,et al.Production of C-reactive proteim and rick of coronary events in stable and unstable angina European concerted action on thrombosis and disabilities angina pectoris study group[J].Lancet,1997,349:462-466.
4Tonari Y, Chida M, Koyama T, et al. Establishment of a reference interval for highly sensitive CRP by exclusion of individuals with abnormal values in related laboratory tests[J]. Japanese Journal of Clinical Pathology,2001,49(2):178-182.
5Winston L. Hutchinson, Wolfgang Koenig, Margit Frohlich, et al. Immunoradiometric assay of circulating C-Reactive Protein:age-related values in the adult general population [J]. Clinical Chemistry, 2000;46(7): 934-938.
6Ira S. Ockene,Charles E. Matthews,Nader Rifal,et al. Variability and classification accuracy of serial High-Sensitivity C-Reactive Protein measurements in healthy adults [J]. Clinical Chemistry,2001,47 (3): 444-450.
7National Committee for Clinical Laboratory Standards. How to define and determine reference intervals in the clinical laboratory; Approved Guideline [M]. NCCLS document C28-A2. PA:NCCLS, 1995, 105.
8Libby P,Ridker PM, Maseri A. Inflammation and therosclerosis[J]. Circulation,2002,105 (9) :1135-1143.
9Rifai N, Ridker PM. High-sensitivity C-reative Protein:a novel and promising marker of coronary heart disease [J]. Clinical Chemistry, 2001,47(3) :403-411.
10Libby P, Ridker PM. Novel inflammatory makers of coronary risk: theory versus practice [J]. Circulation, 1999,100(11): 1148-1150.
